Hemangioendothelioma Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Efficacy and Safety of Different Concentrations of Sirolimus in the Treatment of Kaposiform Hemangioendothelioma.
Condition: Kaposiform Hemangioendothelioma Intervention: Drug: Sirolimus Sponsor: West China Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2021 Category: Research Source Type: clinical trials
Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma
Conditions: Kaposiform Hemangioendothelioma; Kasabach-Merritt Syndrome Intervention: Drug: Sirolimus Sponsor: Children's Hospital of Fudan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 26, 2020 Category: Research Source Type: clinical trials
